Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients

Por Azria, D, Gourgou, S, Sozzi, W J, Zouhair, A, Mirimanoff, R O, Kramar, A, Lemanski, C, Dubois, J B, Romieu, G, Pelegrin, A, Ozsahin, M
Publicado em 2004

Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial(†)

Por Bourgier, C., Kerns, S., Gourgou, S., Lemanski, C., Gutowski, M., Fenoglietto, P., Romieu, G., Crompton, N., Lacombe, J., Pèlegrin, A., Ozsahin, M., Rosenstein, B., Azria, D.
Publicado no Ann Oncol (2016)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

Por Miles, D W, de Haas, S L, Dirix, L Y, Romieu, G, Chan, A, Pivot, X, Tomczak, P, Provencher, L, Cortés, J, Delmar, P R, Scherer, S J
Publicado em 2013

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

Por Mauriac, L, Luporsi, E, Cutuli, B, Fourquet, A, Garbay, J R, Giard, S, Spyratos, F, Sigal-Zafrani, B, Dilhuydy, J M, Acharian, V, Balu-Maestro, C, Blanc-Vincent, M P, Cohen-Solal, C, De Lafontan, B, Dilhuydy, M H, Duquesne, B, Gilles, R, Lesur, A, Shen, N, Cany, L, Dagousset, I, Gaspard, M H, Hoarau, H, Hubert, A, Monira, M H, Perrié, N, Romieu, G
Publicado em 2003